E-LIB Suche - Ergebnisse für: Nicholas, Alan

1

Tu1578 IMBRAVE150: EXPLORATORY EFFICACY AND SAFETY RESULTS ..:

Finn, Richard S. ; Breder, Valeriy ; Vogel, Arndt...
Gastroenterology. 166 (2024) 5 - p. S-1738 , 2024

Link: https://doi.org/10.1016/..

2

Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Ce..:

Karam, Jose Antonio ; Uzzo, Robert ; Bex, Axel...
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

3

Efficacy and Safety of Atezolizumab Plus Bevacizumab vs Sor..:

Finn, Richard S. ; Galle, Peter R. ; Ducreux, Michel...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

4

Artificial Intelligence–Powered Assessment of Pathologic Re..:

Dacic, Sanja ; Travis, William D. ; Giltnane, Jennifer M....
Journal of Thoracic Oncology. 19 (2024) 5 - p. 719-731 , 2024

Link: https://doi.org/10.1016/..

5

Surgical results of the Lung Cancer Mutation Consortium 3 t..:

Rusch, Valerie W. ; Nicholas, Alan ; Patterson, G. Alexander...
The Journal of Thoracic and Cardiovascular Surgery. 165 (2023) 3 - p. 828-839.e5 , 2023

Link: https://doi.org/10.1016/..

6

Author Correction: Neoadjuvant atezolizumab for resectable ..:

Chaft, Jamie E. ; Oezkan, Filiz ; Kris, Mark G....
Nature Medicine. 30 (2023) 1 - p. 303-303 , 2023

Link: https://doi.org/10.1038/..

7

Pertuzumab plus high-dose trastuzumab for HER2-positive bre..:

Lin, Nancy U. ; Kumthekar, Priya ; Sahebjam, Solmaz...
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Overall Survival by Response to First-line Induction Treatm..:

Grande, Enrique ; Bamias, Aristotelis ; Galsky, Matthew D....
European Urology Open Science. 58 (2023) - p. 28-36 , 2023

Link: https://doi.org/10.1016/..

9

Neoadjuvant atezolizumab for resectable non-small cell lung..:

Chaft, Jamie E. ; Oezkan, Filiz ; Kris, Mark G....
Nature Medicine. 28 (2022) 10 - p. 2155-2161 , 2022

Link: https://doi.org/10.1038/..

10

Plasma-Based Measurements of Tumor Heterogeneity Correlate ..:

Yaung, Stephanie J. ; Ju, Christine ; Gattam, Sandeep...
Cancers. 14 (2022) 9 - p. 2240 , 2022

Link: https://doi.org/10.3390/..

11

Atezolizumab plus Bevacizumab versus Sorafenib for Unresect..:

Li, Daneng ; Toh, Han Chong ; Merle, Philippe...
Liver Cancer. 11 (2022) 6 - p. 558-571 , 2022

Link: https://doi.org/10.1159/..

12

Updated efficacy and safety data from IMbrave150: Atezolizu..:

Cheng, Ann-Lii ; Qin, Shukui ; Ikeda, Masafumi...
Journal of Hepatology. 76 (2022) 4 - p. 862-873 , 2022

Link: https://doi.org/10.1016/..

13

QOLP-02. PATIENT-REPORTED OUTCOMES FOLLOWING PERTUZUMAB PLU..:

Kumthekar, Priya ; Sahebjam, Solmaz ; Pegram, Mark...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii174-ii175 , 2020

Link: https://doi.org/10.1093/..

14

Phase II Randomized Trial of Sequential or Concurrent FOLFO..:

Hurwitz, Herbert I. ; Tan, Benjamin R. ; Reeves, James A....
The Oncologist. 24 (2018) 7 - p. 921-932 , 2018

Link: https://doi.org/10.1634/..

15

Developmental change in the influence of domain-general abi..:

Geary, David C. ; Nicholas, Alan ; Li, Yaoran.
Journal of Educational Psychology. 109 (2017) 5 - p. 680-693 , 2017

Link: https://doi.org/10.1037/..